About Leen Kawas
Dr. Kawas is now the Managing General Partner of Propel Bio Partners.
She is the co-founder of Athira and a co-inventor of its lead drug candidate ATH-1017.
She also invented several of the innovative drug candidates in Athira’s pipeline.
In the Press
As a notable CEO at the intersection of technology and biotech, Dr. Kawas is often featured in various industry media.